US20010013349A1 - Apparatus for wrinkle removal - Google Patents
Apparatus for wrinkle removal Download PDFInfo
- Publication number
- US20010013349A1 US20010013349A1 US09/263,422 US26342299A US2001013349A1 US 20010013349 A1 US20010013349 A1 US 20010013349A1 US 26342299 A US26342299 A US 26342299A US 2001013349 A1 US2001013349 A1 US 2001013349A1
- Authority
- US
- United States
- Prior art keywords
- radiation
- laser
- delivery system
- skin
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00747—Dermatology
- A61B2017/00761—Removing layer of skin tissue, e.g. wrinkles, scars or cancerous tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
Definitions
- the present invention relates to a method of reducing wrinkles from a superficial area of mammalian skin tissue, and apparatus therefor.
- wrinkle removal is where laser energy vaporizes thin layers of the epidermis without breaking through the basal layer into the dermis. This is essentially a superficial process primarily used to give the skin a “fresher” appearance.
- wrinkle removal as a more aggressive technique where tissue is removed layer by layer, invading the dermis and effectively inducing a second degree burn. Heat is deposited in the dermis shrinking the collagen and tightening the skin.
- the wavelength is chosen so that the laser energy is highly absorbed in water, the current lasers of choice being the CO 2 laser at 10.6 ⁇ m wavelength and the Erbium YAG laser at 2.94 ⁇ m wavelength.
- pulses of laser energy are applied to the skin surface, each pulse vaporizing a layer of tissue between 30 ⁇ m to 60 ⁇ m in thickness.
- the first pass of the laser removes a thin layer of the epidermis without damaging the basal layer.
- Successive passes over the same area penetrate into the dermis and heat the collagen.
- the laser operator sees this thermal build-up “shrink” the skin in “real time”, tightening up the skin's appearance.
- the operator ceases applying laser pulses. It is therefore apparent that the quality of the cosmetic result is highly dependent upon the experience and skill of the operator.
- the laser induces denaturing of the collagen in the dermis, and the formation of cross links, which results in a tightening effect stretching the skin, reducing or removing the wrinkles (it is thought that the thermal threshold for this effect is a temperature of 70° C.);
- the skin-resurfacing and wrinkle removal procedure outlined above is considered by many experts in the field as a significant improvement over previously used surgical methods.
- the procedure uses the laser's ability to deliver high energy density at the surface of tissue and hence ablate the surface tissue in a well controlled manner.
- layer by layer is designed to damage the collagen and hence induce wrinkle removal.
- This second stage of the procedure is primitive; the skin weeps, scabs form and redness of the skin appears for many weeks.
- the present invention provides a method of removing wrinkles from a superficial area of mammalian skin tissue.
- the dermal layer of the tissue is irradiated through the basal layer by radiation selected to be absorbed by a chromophore in the dermal layer such that collagen present in the dermal layer is heated, while the basal layer remains intact so as to substantially inhibit contact of the dermal layer with ambient air.
- the invention provides apparatus for cosmetic reduction of wrinkles on a superficial area of mammalian skin, the apparatus comprising a radiation delivery system for delivering a radiation beam of predetermined monochromatic wavelength or narrow wavelength bandwidth to the skin, the radiation delivery system including a pulsation system for pulsing the radiation delivered according to a predetermined regime, and an optical arrangement for focussing the beam such that the total radiation energy density delivered to the skin in substantially in the range 0.5 J/cm 2 to 5 J/cm 2 per pulse.
- the irradiation of the dermal layer in the method according to the invention is tailored to shrink the skin tissue without damage to the dermis (in other words, without causing second degree burns) because the barrier provided by the basal layer remains intact. This is achieved by selecting the required radiation wavelength to match the characteristic absorbtion wavelength of the chromophore whilst being absorbed to an insignificant degree in the epidermis and basal layer.
- the energy delivered per pulse is also tailored to ensure that ablation does not occur of the target structure, but rather that energy absorbed in the target provides sufficient heating that heat energy diffusing outwards from the target heats the surrounding tissues to a degree sufficient to thermally induce shrinkage of the surrounding tissue and also stimulate the production of new tissue components such as elastin and collagen.
- the target for the laser has an appropriate chromophore (a substance that absorbs a specific wavelength and transmits or scatters at other wavelengths) then the laser can be used to modify that target selectively within an inhomogeneous volume of tissue. Occasionally, the desired target does not have a suitable chromophore of its own but exists in close proximity to another material which has such a chromophore which can be selectively targeted. Such interaction is called secondary selective interaction.
- An artificial chromphore may be introduced into the desired area for wrinkle reduction, or a naturally occurring chromophore may be selected.
- the naturally occurring chromophore selected is oxyhemoglobin of the dermal plexus which has wavelength absorbtion peaks at 585 nm and 815 nm, at which wavelengths absorbtion in surrounding tissue components is relatively low.
- the invention therefore provides apparatus for cosmetic reduction of wrinkles on a superficial area of mammalian skin, the apparatus comprising a radiation delivery system for delivering substantially monochromatic radiation in a bandwidth of substantially 15 nm or less in at least one of the ranges 570 nm to 600 nm and 750 nm to 850 nm, the delivery system including a pulsation system for pulsing the radiation delivered according to a predetermined regime in which the energy density of the substantially monochromatic radiation in the bandwidth of substantially 15 nm or less delivered to the skin is substantially in the range 0.5 J/cm 2 to 5 J/cm 2 per pulse.
- the method according to the invention is non-invasive and non-ablative and can readily be performed by non-medical personnel.
- the total energy delivered per pulse is sufficient to effect the required physical change in the tissue surrounding the target chromophore without causing ablation of the target or other skin components through which the radiation passes.
- the radiation is preferably substantially monochromatic or at least of a relatively narrow wavelength bandwidth to ensure that it is preferentially selectively absorbed by the target chromophore.
- a laser source may be used to produce the required wavelength, or a light source, such as an LED may be used with appropriate filtering to permit the selected wavelength (or narrow wavelength band) to pass.
- the irradiation may be by means of a source of visible or infra-red radiation (suitably filtered to remove deleterious ultra-violet radiation if necessary).
- the radiation may be coherent (that is from a laser source).
- a laser source may be, for example, a dye laser, a ruby laser, or a semiconductor laser. If a dye laser is used, its wavelength is preferably such that it is absorbed by oxyhemoglobin (as naturally occurring chromophore present in blood vessels in the dermis).
- the superficial area may be treated with an artificial chromophore which is absorbed into the dermal layer.
- an artificial chromophore may be applied to the epidermal layer in the form of a liposome-containing topical formulation. The chromophore may then permeate through the basal layer for delivery to the dermal layer.
- a laser When a laser is used, it may be arranged to scan the superficial area and/or to irradiate the dermal layer in pulses. When the laser is in pulsed mode, the pulses typically have duration of 10 ⁇ sec to 10 msec (more preferably 200 ⁇ sec to 1 msec).
- epidermis removal may be effected mechanically (for example by abrasion), or by means of laser radiation.
- laser radiation is typically a scanner controlled CO 2 laser source.
- the energy density per pulse is preferably accurately controlled to ensure that a maximum threshold level (substantially of 5 J/cm 2 ) is not exceeded.
- FIG. 1 is a schematic representation of the three outermost layers of mammalian skin tissue
- FIG. 2 is a schematic representation of partial removal of the epidermis (skin resurfacing), which is an optional step according to the invention
- FIG. 3 is a schematic illustration of the result of a prior art method of wrinkle removal, which is surgical because it involves full removal of the epidermis in a selected area and therefore exposure of the dermis and consequent second degree burning;
- FIG. 4 is a schematic illustration of the result of the method according to the invention, showing that the epidermis is partially intact and the basal layer fully intact;
- FIG. 5 is a schematic diagram of a first embodiment of wrinkle reduction apparatus according to the invention.
- FIG. 6 is a schematic diagram of an alternate embodiment of wrinkle reduction apparatus according to the invention.
- FIG. 7 is a schematic representation of an optical delivery system forming part of apparatus according to the invention.
- FIG. 8 is a graphical representation showing the intensity profile of the radiation delivered using apparatus according to the invention.
- the basic skin structure of mammalian skin tissue comprises three layers, the outermost epidermis 1 which is adjacent to the basal layer 2 and then the dermis 3 .
- partial removal of an area 4 of epidermis 1 by means of CO 2 laser radiation is known as skin resurfacing.
- This stage represents the first step of a prior art method but is an optional step according to the invention. Both the basal layer 2 and the dermis 3 are unaffected by the laser radiation.
- prior art method of wrinkle removal results in complete removal of an area 5 of epidermis 1 and basal layer 2 by repeated exposure to CO 2 laser radiation. Partial removal of the dermis 3 also occurs, as represented by 6 , leaving the dermis exposed to air. This causes a second degree burn which is slow to heal and a risk of infection.
- the method of wrinkle removal according to the invention results in partial removal of the epidermis 1 (this is an optional step as described in FIG. 2 above) and the basal layer 2 is left intact, such that the dermis 3 is not exposed to air.
- Laser radiation 7 is applied to the tissue and selectively absorbed by a chromophore in the dermis 3 , heating the collagen and shrinking the skin hence removing the appearance of wrinkles.
- the target chromophore selected is oxyhemoglobin in the dermis 3 which has absorbtion peaks at approximately 585 nm and 815 nm.
- the apparatus shown in FIG. 5 comprises a laser radiation delivery system 101 comprising a flashlamp excited pumped dye laser including a laser head 102 , dye reservoir 103 and pump 104 .
- a flowmeter 105 regulates dye flow to the laser cavity in the laser head 102 and a cooling system 106 cools the laser head 102 and dye reservoir 103 .
- the system is controlled by a microprocessor controller 107 which operates voltage control of a pulse forming network 108 (including a capacitor and inductor network) which initiates a discharge pulse and consequently a pulsed beam laser output from laser head 102 .
- Voltage control and feedback is provided between the microprocessor controller 107 and pulse forming network 108 via link 109 .
- Temperature monitoring feedback is provided between the cooling system and the controller 107 via link 110 .
- the laser head operates to output controlled pulses of laser radiation having wavelength in the range 577 nm to 585 nm and a pulse duration in the range 200 ⁇ s to 1 ms.
- an appropriate laser dye is selected (such as Rhodamine 575 or Pyromethane 590), the concentration of the dye solution is controlled.
- Control of the pulse duration for the dye laser arrangement 101 is achieved by accurate control of the energy delivered to the exciting flashlamps in the laser head 102 by tailoring the capacitor and inductor values in the pulse forming network 108 .
- the energy is delivered to the skin surface via a fiberoptic tube 112 (see FIG. 7) and a focussing optical lens arrangement 113 which is configured to focus a light spot onto the skin tissue surface so as to have a spot diameter within the range 1 mm to 10 mm, and an intensity distribution across the spot diameter that is substantially uniform (i.e. “a top hat” distribution), as shown in FIG. 8.
- a top hat intensity distribution across the spot diameter that is substantially uniform
- the radiation parameters are also selected to ensure that the total radiation energy density delivered per pulse falls within the range 0.5 J/cm 2 to 5 J/cm 2 . It is particularly important that the selected upper threshold value (5 J/cm 2 ) is not exceeded significantly as delivery of a higher energy densities of radiation per pulse can result in unwanted effects on the skin (such as ablation and/or other damage).
- the energy density of the radiation delivered to the skin is controlled by adjustment of the flashlamp output energy (which in turn controls the laser output energy).
- the laser output energy in conjunction with the spot site determines the energy density delivered.
- Accurate control is achieved by control of the dye circulation rate, the dye temperature and the flashlamp output energy.
- Dye circulation rate is important because repeated pulsing of the same volume of dye, without circulation, reduces the output energy of the laser head 102 .
- Increasing or decreasing the dye temperature has an affect on the energy output of the laser head 102 .
- the flashlamp output energy is controlled by varying the voltage with which the capacitors in the pulse forming network 108 are charged; feedback of the capacitor voltage via link 109 is therefore important.
- the energy density required will vary within the specified range from person to person, depending upon skin colour.
- FIG. 6 there is shown an alternative embodiment of apparatus for performance of the invention in which an LED or semiconductor laser device 202 may be utilised to produce the output radiation 220 .
- a user interface 213 enables input into a microprocessor controller 207 which is used to control a power supply unit 214 to ensure that the required current is supplied to the LED or semiconductor laser device 220 .
- a temperature sensor 215 provides temperature feedback via a link 210 .
- Output 216 from controller 207 sets the current supplied by the power supply unit 214 to the device 202 ; input 217 into the controller 207 provides current monitoring feedback. Control of the pulse duration is achieved by pulsing the current supply from power supply unit 214 to the LED or semiconductor laser device 202 .
- High intensity LED devices are capable of producing wavelengths corresponding to the 585 nm absorption peak of oxyhaemoglobin.
- the optical system may include filters arranged to narrow the band of radiation passing from the LED to the target area of the skin. Where lasers are used, the output may be monochromatic. Alternatively, or in the case where LED's are used, the radiation delivered may be “effectively” monochromatic, or of a relatively narrow band width (typically within a band width of 15 nm or less).
- the output may correspond to the second (higher) absorption peak (815 nm) for oxyhaemoglobin.
- the wavelength is selected to correspond to a characteristic absorption wavelength of the relevant chromophore. It remains important to ensure that the total energy delivered per pulse is below the threshold damage level (approximately 5 J/cm 2 ).
- the inter pulse duration is selected at a level to avoid this situation occurring. It is preferred that the pulse repetition rate is substantially in the range 3 Hz maximum or less.
Abstract
Wrinkles are cosmetically removed from a superficial area of mammalian skin tissue having an epidermal layer, a basal layer, and a dermal layer, by irradiating the dermal layer through the basal layer, the irradiation being selected to be absorbed by a chromphore in the dermal layer such that collagen present in the dermal layer is heated, while the basal layer remains intact so as to substantially inhibit contact of the dermal layer with ambient air.
Description
- This is a Continuation In Part of U.S. patent application Ser. No. 08/919472 filed on Aug. 28, 1997
- The present invention relates to a method of reducing wrinkles from a superficial area of mammalian skin tissue, and apparatus therefor.
- The application of laser technology in healthcare is well known, and the use of lasers in medical applications has been studied extensively since the early 1960's. In recent years an increasing interest has been shown in cosmetic applications. Two such cosmetic applications are skin resurfacing and wrinkle removal; in this field lasers can be used as an alternative to surgical facelifts.
- There is a distinct difference between wrinkle removal and skin resurfacing. Skin resurfacing is where laser energy vaporizes thin layers of the epidermis without breaking through the basal layer into the dermis. This is essentially a superficial process primarily used to give the skin a “fresher” appearance. However, wrinkle removal as a more aggressive technique where tissue is removed layer by layer, invading the dermis and effectively inducing a second degree burn. Heat is deposited in the dermis shrinking the collagen and tightening the skin.
- In young skin, the collagen just beneath the surface of the skin forms an organized lattice with good elasticity and flexibility. During aging, the collagen changes its structure impacting negatively on the cosmetic appearance of the skin. Several techniques have been developed to induce a “controlled injury” to the dermis in an attempt to generate rejuvenation of the collagen structure returning the skin to an earlier cosmetic appearance. During the 1990's a laser approach to wrinkle removal has been introduced.
- For know wrinkle removal techniques, the wavelength is chosen so that the laser energy is highly absorbed in water, the current lasers of choice being the CO2 laser at 10.6 μm wavelength and the Erbium YAG laser at 2.94 μm wavelength. In this non-selective process, pulses of laser energy are applied to the skin surface, each pulse vaporizing a layer of tissue between 30 μm to 60 μm in thickness. Normally, the first pass of the laser removes a thin layer of the epidermis without damaging the basal layer. Successive passes over the same area penetrate into the dermis and heat the collagen. The laser operator sees this thermal build-up “shrink” the skin in “real time”, tightening up the skin's appearance. When the desired clinical outcome is achieved, the operator ceases applying laser pulses. It is therefore apparent that the quality of the cosmetic result is highly dependent upon the experience and skill of the operator.
- In the case of CO2 laser wrinkle removal, post treatment supervision of the patient is a necessity immediately after treatment, the skin is essentially an open wound requiring dressings in place for 2-10 days. Additionally, topically applied lotions are required for patient comfort and prevention of infection. Post-operative infection is common, primarily due to removal of the natural protective barrier of the skin, with a reported incidence of between 4.5 to 7%.
- On average, with CO2 laser wrinkle removal, post-treatment crythema is present for 4-5 months. This compares to 2-3 months following a Chemical Peel. Also, the incidence of side effects is significant, the most common being hyperpigmentation occurring in 30-40% of cases. Higher incidences are reported in darker skin types. A delayed hyperpigmentation, which can occur up to a year after the procedure was performed, has recently emerged as a complication of aggressive laser resurfacing. Many of the eminent laser resurfacing surgeons have reported to less aggressive techniques.
- The effect of known procedures is two fold:
- (a) the laser induces denaturing of the collagen in the dermis, and the formation of cross links, which results in a tightening effect stretching the skin, reducing or removing the wrinkles (it is thought that the thermal threshold for this effect is a temperature of 70° C.); and
- (b) the changes to the dermis induce the generation of new collagen which develops using the matrix created by the denatured collagen as a foundation.
- The skin-resurfacing and wrinkle removal procedure outlined above is considered by many experts in the field as a significant improvement over previously used surgical methods. The procedure uses the laser's ability to deliver high energy density at the surface of tissue and hence ablate the surface tissue in a well controlled manner. Continuing to remove the tissue, layer by layer is designed to damage the collagen and hence induce wrinkle removal. This second stage of the procedure is primitive; the skin weeps, scabs form and redness of the skin appears for many weeks.
- It is therefore the primary object of the present invention to provide a technique for removing wrinkles from a superficial area of mammalian skin tissue without causing secondary burns and other problems associated with traditional wrinkle removal.
- The present invention provides a method of removing wrinkles from a superficial area of mammalian skin tissue. The dermal layer of the tissue is irradiated through the basal layer by radiation selected to be absorbed by a chromophore in the dermal layer such that collagen present in the dermal layer is heated, while the basal layer remains intact so as to substantially inhibit contact of the dermal layer with ambient air.
- According to a further aspect, the invention provides apparatus for cosmetic reduction of wrinkles on a superficial area of mammalian skin, the apparatus comprising a radiation delivery system for delivering a radiation beam of predetermined monochromatic wavelength or narrow wavelength bandwidth to the skin, the radiation delivery system including a pulsation system for pulsing the radiation delivered according to a predetermined regime, and an optical arrangement for focussing the beam such that the total radiation energy density delivered to the skin in substantially in the range 0.5 J/cm2 to 5 J/cm2 per pulse.
- The irradiation of the dermal layer in the method according to the invention is tailored to shrink the skin tissue without damage to the dermis (in other words, without causing second degree burns) because the barrier provided by the basal layer remains intact. This is achieved by selecting the required radiation wavelength to match the characteristic absorbtion wavelength of the chromophore whilst being absorbed to an insignificant degree in the epidermis and basal layer. The energy delivered per pulse is also tailored to ensure that ablation does not occur of the target structure, but rather that energy absorbed in the target provides sufficient heating that heat energy diffusing outwards from the target heats the surrounding tissues to a degree sufficient to thermally induce shrinkage of the surrounding tissue and also stimulate the production of new tissue components such as elastin and collagen.
- If the target for the laser has an appropriate chromophore (a substance that absorbs a specific wavelength and transmits or scatters at other wavelengths) then the laser can be used to modify that target selectively within an inhomogeneous volume of tissue. Occasionally, the desired target does not have a suitable chromophore of its own but exists in close proximity to another material which has such a chromophore which can be selectively targeted. Such interaction is called secondary selective interaction.
- An artificial chromphore may be introduced into the desired area for wrinkle reduction, or a naturally occurring chromophore may be selected. In a preferred embodiment of the technique, the naturally occurring chromophore selected is oxyhemoglobin of the dermal plexus which has wavelength absorbtion peaks at 585 nm and 815 nm, at which wavelengths absorbtion in surrounding tissue components is relatively low.
- According to a further aspect, the invention therefore provides apparatus for cosmetic reduction of wrinkles on a superficial area of mammalian skin, the apparatus comprising a radiation delivery system for delivering substantially monochromatic radiation in a bandwidth of substantially 15 nm or less in at least one of the ranges 570 nm to 600 nm and 750 nm to 850 nm, the delivery system including a pulsation system for pulsing the radiation delivered according to a predetermined regime in which the energy density of the substantially monochromatic radiation in the bandwidth of substantially 15 nm or less delivered to the skin is substantially in the range 0.5 J/cm2 to 5 J/cm2 per pulse.
- The method according to the invention is non-invasive and non-ablative and can readily be performed by non-medical personnel. The total energy delivered per pulse is sufficient to effect the required physical change in the tissue surrounding the target chromophore without causing ablation of the target or other skin components through which the radiation passes.
- The radiation is preferably substantially monochromatic or at least of a relatively narrow wavelength bandwidth to ensure that it is preferentially selectively absorbed by the target chromophore. A laser source may be used to produce the required wavelength, or a light source, such as an LED may be used with appropriate filtering to permit the selected wavelength (or narrow wavelength band) to pass.
- The irradiation may be by means of a source of visible or infra-red radiation (suitably filtered to remove deleterious ultra-violet radiation if necessary). The radiation may be coherent (that is from a laser source). Such a laser source may be, for example, a dye laser, a ruby laser, or a semiconductor laser. If a dye laser is used, its wavelength is preferably such that it is absorbed by oxyhemoglobin (as naturally occurring chromophore present in blood vessels in the dermis).
- alternatively, the superficial area may be treated with an artificial chromophore which is absorbed into the dermal layer. Such an artificial chromophore may be applied to the epidermal layer in the form of a liposome-containing topical formulation. The chromophore may then permeate through the basal layer for delivery to the dermal layer.
- When a laser is used, it may be arranged to scan the superficial area and/or to irradiate the dermal layer in pulses. When the laser is in pulsed mode, the pulses typically have duration of 10 μsec to 10 msec (more preferably 200 μsec to 1 msec).
- It is sometimes desirable to remove part of the epidermic prior to irradiating the dermal layer according to the invention. Such epidermis removal (known as skin resurfacing) may be effected mechanically (for example by abrasion), or by means of laser radiation. When laser radiation is used for this purpose, it is typically a scanner controlled CO2 laser source.
- The energy density per pulse is preferably accurately controlled to ensure that a maximum threshold level (substantially of 5 J/cm2) is not exceeded.
- FIG. 1 is a schematic representation of the three outermost layers of mammalian skin tissue;
- FIG. 2 is a schematic representation of partial removal of the epidermis (skin resurfacing), which is an optional step according to the invention;
- FIG. 3 is a schematic illustration of the result of a prior art method of wrinkle removal, which is surgical because it involves full removal of the epidermis in a selected area and therefore exposure of the dermis and consequent second degree burning;
- FIG. 4 is a schematic illustration of the result of the method according to the invention, showing that the epidermis is partially intact and the basal layer fully intact;
- FIG. 5, is a schematic diagram of a first embodiment of wrinkle reduction apparatus according to the invention;
- FIG. 6 is a schematic diagram of an alternate embodiment of wrinkle reduction apparatus according to the invention;
- FIG. 7 is a schematic representation of an optical delivery system forming part of apparatus according to the invention; and,
- FIG. 8 is a graphical representation showing the intensity profile of the radiation delivered using apparatus according to the invention.
- Referring to FIG. 1, the basic skin structure of mammalian skin tissue comprises three layers, the
outermost epidermis 1 which is adjacent to thebasal layer 2 and then thedermis 3. - Referring to FIG. 2, partial removal of an
area 4 ofepidermis 1 by means of CO2 laser radiation is known as skin resurfacing. This stage represents the first step of a prior art method but is an optional step according to the invention. Both thebasal layer 2 and thedermis 3 are unaffected by the laser radiation. - As shown in FIG. 3, prior art method of wrinkle removal results in complete removal of an
area 5 ofepidermis 1 andbasal layer 2 by repeated exposure to CO2 laser radiation. Partial removal of thedermis 3 also occurs, as represented by 6, leaving the dermis exposed to air. This causes a second degree burn which is slow to heal and a risk of infection. - As shown in FIG. 4, the method of wrinkle removal according to the invention results in partial removal of the epidermis1 (this is an optional step as described in FIG. 2 above) and the
basal layer 2 is left intact, such that thedermis 3 is not exposed to air.Laser radiation 7 is applied to the tissue and selectively absorbed by a chromophore in thedermis 3, heating the collagen and shrinking the skin hence removing the appearance of wrinkles. - In a preferred embodiment, the target chromophore selected is oxyhemoglobin in the
dermis 3 which has absorbtion peaks at approximately 585 nm and 815 nm. The apparatus shown in FIG. 5 comprises a laser radiation delivery system 101 comprising a flashlamp excited pumped dye laser including alaser head 102,dye reservoir 103 and pump 104. Aflowmeter 105 regulates dye flow to the laser cavity in thelaser head 102 and a cooling system 106 cools thelaser head 102 anddye reservoir 103. The system is controlled by amicroprocessor controller 107 which operates voltage control of a pulse forming network 108 (including a capacitor and inductor network) which initiates a discharge pulse and consequently a pulsed beam laser output fromlaser head 102. Voltage control and feedback is provided between themicroprocessor controller 107 and pulse forming network 108 via link 109. Temperature monitoring feedback is provided between the cooling system and thecontroller 107 via link 110. - The laser head operates to output controlled pulses of laser radiation having wavelength in the range 577 nm to 585 nm and a pulse duration in the range 200 μs to 1 ms. To produce the required wavelength an appropriate laser dye is selected (such as Rhodamine 575 or Pyromethane 590), the concentration of the dye solution is controlled.
- Control of the pulse duration for the dye laser arrangement101 is achieved by accurate control of the energy delivered to the exciting flashlamps in the
laser head 102 by tailoring the capacitor and inductor values in the pulse forming network 108. - The energy is delivered to the skin surface via a fiberoptic tube112 (see FIG. 7) and a focussing optical lens arrangement 113 which is configured to focus a light spot onto the skin tissue surface so as to have a spot diameter within the
range 1 mm to 10 mm, and an intensity distribution across the spot diameter that is substantially uniform (i.e. “a top hat” distribution), as shown in FIG. 8. Providing optics to ensure that the uniform energy distribution results in even heating of the tissue without the occurrence of “hot spots” which could result in tissue damage/oblation. - The radiation parameters are also selected to ensure that the total radiation energy density delivered per pulse falls within the range 0.5 J/cm2 to 5 J/cm2. It is particularly important that the selected upper threshold value (5 J/cm2) is not exceeded significantly as delivery of a higher energy densities of radiation per pulse can result in unwanted effects on the skin (such as ablation and/or other damage).
- For the dye laser system101 of FIG. 1, the energy density of the radiation delivered to the skin is controlled by adjustment of the flashlamp output energy (which in turn controls the laser output energy). The laser output energy in conjunction with the spot site determines the energy density delivered. Accurate control is achieved by control of the dye circulation rate, the dye temperature and the flashlamp output energy. Dye circulation rate is important because repeated pulsing of the same volume of dye, without circulation, reduces the output energy of the
laser head 102. Increasing or decreasing the dye temperature has an affect on the energy output of thelaser head 102. The flashlamp output energy is controlled by varying the voltage with which the capacitors in the pulse forming network 108 are charged; feedback of the capacitor voltage via link 109 is therefore important. - The energy density required will vary within the specified range from person to person, depending upon skin colour.
- Referring to FIG. 6, there is shown an alternative embodiment of apparatus for performance of the invention in which an LED or
semiconductor laser device 202 may be utilised to produce the output radiation 220. Auser interface 213 enables input into amicroprocessor controller 207 which is used to control apower supply unit 214 to ensure that the required current is supplied to the LED or semiconductor laser device 220. Atemperature sensor 215 provides temperature feedback via a link 210.Output 216 fromcontroller 207 sets the current supplied by thepower supply unit 214 to thedevice 202;input 217 into thecontroller 207 provides current monitoring feedback. Control of the pulse duration is achieved by pulsing the current supply frompower supply unit 214 to the LED orsemiconductor laser device 202. - High intensity LED devices are capable of producing wavelengths corresponding to the 585 nm absorption peak of oxyhaemoglobin. The optical system (including lens113) may include filters arranged to narrow the band of radiation passing from the LED to the target area of the skin. Where lasers are used, the output may be monochromatic. Alternatively, or in the case where LED's are used, the radiation delivered may be “effectively” monochromatic, or of a relatively narrow band width (typically within a band width of 15 nm or less).
- Where a semiconductor laser device is used, the output may correspond to the second (higher) absorption peak (815 nm) for oxyhaemoglobin.
- Whilst the invention has been described in relation to delivery of effectively monochromatic radiation (or within specific narrow band widths) at one or other of the oxyhaemoglobin absorption peaks of 585 nm and 815 nm, it is clear that the beneficial effect of the invention can be achieved to a certain degree by using wavelengths relatively close to, but either side, of the respective absorption peaks. Preferred wavelength ranges for operation are 570 nm to 600 nm and 750 nm to 850 nm for targeting oxyhaemoglobin.
- Where an artificial chromophore is used, the wavelength (or narrow band of wavelengths) is selected to correspond to a characteristic absorption wavelength of the relevant chromophore. It remains important to ensure that the total energy delivered per pulse is below the threshold damage level (approximately 5 J/cm2).
- In the embodiment described, it is important to ensure that there is not excess energy (and therefore heat) build-up in the target, and therefore the inter pulse duration is selected at a level to avoid this situation occurring. It is preferred that the pulse repetition rate is substantially in the
range 3 Hz maximum or less.
Claims (26)
1. Apparatus for cosmetic reduction of wrinkles on superficial mammalian skin, the apparatus comprising a radiation delivery system for delivering substantially monochromatic radiation, said radiation being in a wavelength bandwidth of substantially 15 nm or less and in at least one of the ranges 570 nm to 600 nm and 750 nm to 850 nm, the delivery system including a pulsation system for pulsing the radiation delivered according to a predetermined regime in which the radiation delivered to the skin has an energy density substantially in the range 0.5 J/cm2 to 5 J/cm2 per pulse.
2. Apparatus according to , wherein the radiation delivery system is set up to deliver the substantially monochromatic radiation in a bandwidth of substantially 15 nm or less substantially in at least one of the ranges 577 nm to 585 nm and 800 nm to 815 nm.
claim 1
3. Apparatus according to , wherein the radiation delivery system is set up to deliver radiation in a concentrated beam having a cross section with a substantially uniform energy distribution across said beam cross section.
claim 1
4. Apparatus according to , wherein the radiation delivery system is set up to deliver radiation in a concentrated beam having a diameter substantially in the range 1 mm to 10 mm.
claim 1
5. Apparatus according to , wherein the pulsation system is set up to provide radiation pulses each pulse having a duration substantially in the range 10 μs to 2 ms.
claim 1
6. Apparatus according to , wherein the pulsation system is set up to provide radiation pulses each pulse having a duration substantially in the range 200 μs to 1 ms.
claim 1
7. Apparatus according to , wherein the radiation delivery system comprises a laser radiation delivery system.
claim 1
8. Apparatus according to , wherein the laser radiation delivery system comprises a dye laser radiation delivery system.
claim 7
9. Apparatus according to , wherein the dye laser radiation delivery system comprises a flashlamp pumped dye laser including a pulse forming network arranged to pulse the laser according to the predetermined pulse regime.
claim 8
10. Apparatus according to , wherein the laser radiation delivery system comprises a semiconductor laser radiation delivery system.
claim 7
11. Apparatus according to , wherein the radiation delivery means includes a radiation emitting LED device.
claim 1
12. Apparatus according to , wherein the radiation delivery means includes at least one radiation filter arranged to filter radiation to permit the substantially monochromatic radiation to be delivered to the skin.
claim 11
13. Apparatus according to , further comprising a control system arranged to permit the energy density to be varied within the range 0.5 J/cm2 and 5 J/cm2.
claim 1
14. Apparatus according to , wherein the control means is arranged to inhibit selection of an energy density substantially above 5 J/cm2.
claim 13
15. Apparatus for cosmetic reduction of wrinkles on a superficial area of mammalian skin, the apparatus comprising a radiation delivery system for delivering a radiation beam of predetermined monochromatic wavelength or narrow wavelength bandwidth to the skin, the radiation delivery system including a pulsation system for pulsing the radiation delivered according to a predetermined regime such that the total radiation energy density delivered to the skin is substantially in the range 0.5 J/cm2 to 5 J/cm2 per pulse.
16. Apparatus according to , which includes an optical arrangement for focussing the beam.
claim 15
17. A method of cosmetically removing wrinkles from a superficial area of mammalian skin tissue having, in the order specified, an epidermal layer, a basal layer, and a dermal layer, which method comprises: irradiating said dermal layer through said basal layer by means of visible or infra red radiation, said irradiation being selected to be absorbed by a chromophore in said dermal layer such that collagen present in said dermal layer is heated, while said basal layer remains intact so as to substantially inhibit contact of said dermal layer with ambient air.
18. A method according to , wherein the irradiation is from a substantially monochromatic radiation source in a bandwidth of substantially 15 nm or less.
claim 17
19. A method according to , wherein said irradiation is from a coherent radiation source.
claim 17
20. A method according to , wherein the source comprises a ruby laser arranged to target the dermis.
claim 17
21. A method according to , wherein the source comprises a dye laser of wavelength selected to target oxyhemoglobin present in blood vessels in said dermal layer.
claim 17
22. A method according to , wherein the source comprises a dye laser, a ruby laser, or a semiconductor laser which scans said area of mammalian skin tissue.
claim 17
23. A method according to , wherein the laser comprising said source is pulsed.
claim 22
24. A method according to , wherein the pulsed laser has pulses of duration 10 μsec to 2 msec.
claim 23
25. A method according to , in which said superficial area of mammalian skin tissue is treated with an artificial chromophore which is absorbed into the dermal layer.
claim 17
26. A method according to , wherein the artificial chromophore is applied to the epidermal layer in the form of a liposome containing topical formulation.
claim 25
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/263,422 US6443946B2 (en) | 1996-08-29 | 1999-03-05 | Apparatus for wrinkle removal |
US09/981,077 US20020045891A1 (en) | 1996-08-29 | 2001-12-27 | Wrinkle reduction |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9618051.8 | 1996-08-29 | ||
GBGB9618051.8A GB9618051D0 (en) | 1996-08-29 | 1996-08-29 | Wrinkle removal |
GB9618051 | 1996-08-29 | ||
US08/919,472 US5983900A (en) | 1996-08-29 | 1997-08-28 | Wrinkle removal |
US09/263,422 US6443946B2 (en) | 1996-08-29 | 1999-03-05 | Apparatus for wrinkle removal |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/919,472 Continuation US5983900A (en) | 1996-08-29 | 1997-08-28 | Wrinkle removal |
US08/919,472 Continuation-In-Part US5983900A (en) | 1996-08-29 | 1997-08-28 | Wrinkle removal |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/981,077 Division US20020045891A1 (en) | 1996-08-29 | 2001-12-27 | Wrinkle reduction |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010013349A1 true US20010013349A1 (en) | 2001-08-16 |
US6443946B2 US6443946B2 (en) | 2002-09-03 |
Family
ID=26309944
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/919,472 Expired - Lifetime US5983900A (en) | 1996-08-29 | 1997-08-28 | Wrinkle removal |
US09/263,422 Expired - Fee Related US6443946B2 (en) | 1996-08-29 | 1999-03-05 | Apparatus for wrinkle removal |
US09/981,077 Abandoned US20020045891A1 (en) | 1996-08-29 | 2001-12-27 | Wrinkle reduction |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/919,472 Expired - Lifetime US5983900A (en) | 1996-08-29 | 1997-08-28 | Wrinkle removal |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/981,077 Abandoned US20020045891A1 (en) | 1996-08-29 | 2001-12-27 | Wrinkle reduction |
Country Status (11)
Country | Link |
---|---|
US (3) | US5983900A (en) |
EP (1) | EP0932431B1 (en) |
JP (1) | JP2000517211A (en) |
AU (1) | AU3951197A (en) |
CA (1) | CA2265041C (en) |
DE (1) | DE69728779T2 (en) |
ES (1) | ES2218695T3 (en) |
GB (1) | GB9618051D0 (en) |
NZ (1) | NZ334910A (en) |
WO (1) | WO1998008568A1 (en) |
ZA (1) | ZA977751B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100055789A1 (en) * | 1998-11-30 | 2010-03-04 | Mcdaniel David H | Method and apparatus for the stimulation of hair growth |
US8651111B2 (en) * | 2003-04-10 | 2014-02-18 | David H. McDaniel | Photomodulation methods and devices for regulating cell proliferation and gene expression |
US8651112B2 (en) | 1998-11-30 | 2014-02-18 | David McDaniel | Process for treatment of psoriasis |
US9017391B2 (en) | 1998-11-30 | 2015-04-28 | L'oreal | Method and apparatus for skin treatment |
US9144690B2 (en) | 2003-07-31 | 2015-09-29 | L'oreal | System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US9227082B2 (en) | 1998-11-30 | 2016-01-05 | L'oreal | Method and apparatus for acne treatment using low intensity light therapy |
CN108187240A (en) * | 2017-12-15 | 2018-06-22 | 重庆云帆医疗设备有限公司 | A kind of anti-wrinkle therapeutic equipment |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6104959A (en) | 1997-07-31 | 2000-08-15 | Microwave Medical Corp. | Method and apparatus for treating subcutaneous histological features |
FR2772274B1 (en) * | 1997-12-16 | 2002-01-04 | Galderma Rech Dermatologique | DEVICE COMPRISING A CHROMOPHORE COMPOSITION FOR APPLICATION ON THE SKIN, METHOD FOR MANUFACTURING SUCH A DEVICE AND USES THEREOF |
US20060184071A1 (en) * | 1997-12-29 | 2006-08-17 | Julia Therapeutics, Llc | Treatment of skin with acoustic energy |
US20080027328A1 (en) * | 1997-12-29 | 2008-01-31 | Julia Therapeutics, Llc | Multi-focal treatment of skin with acoustic energy |
US6113559A (en) * | 1997-12-29 | 2000-09-05 | Klopotek; Peter J. | Method and apparatus for therapeutic treatment of skin with ultrasound |
US6325769B1 (en) | 1998-12-29 | 2001-12-04 | Collapeutics, Llc | Method and apparatus for therapeutic treatment of skin |
DE19823947A1 (en) * | 1998-05-28 | 1999-12-02 | Baasel Carl Lasertech | Method and device for superficial heating of tissue |
US7004933B2 (en) * | 1998-05-29 | 2006-02-28 | Light Bioscience L.L.C. | Ultrasound enhancement of percutaneous drug absorption |
US6077294A (en) | 1998-06-11 | 2000-06-20 | Cynosure, Inc. | Method for non-invasive wrinkle removal and skin treatment |
US6059820A (en) | 1998-10-16 | 2000-05-09 | Paradigm Medical Corporation | Tissue cooling rod for laser surgery |
GB9905173D0 (en) | 1999-03-05 | 1999-04-28 | Sls Biophile Limited | Wrinkle reduction |
US6702838B1 (en) | 2000-09-18 | 2004-03-09 | Lumenis Inc. | Method of treating hypotrophic scars enlarged pores |
US7493645B1 (en) | 2000-10-27 | 2009-02-17 | Audiovox Corporation | Console with monitor and wireless receiver |
US6808532B2 (en) | 2000-12-15 | 2004-10-26 | Dan E. Andersen | Laser treatment for reducing wrinkles |
US20080183162A1 (en) * | 2000-12-28 | 2008-07-31 | Palomar Medical Technologies, Inc. | Methods And Devices For Fractional Ablation Of Tissue |
CN101194856A (en) * | 2000-12-28 | 2008-06-11 | 帕洛玛医疗技术有限公司 | Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor |
US7094252B2 (en) * | 2001-08-21 | 2006-08-22 | Cooltouch Incorporated | Enhanced noninvasive collagen remodeling |
US6648904B2 (en) * | 2001-11-29 | 2003-11-18 | Palomar Medical Technologies, Inc. | Method and apparatus for controlling the temperature of a surface |
US20030109860A1 (en) * | 2001-12-12 | 2003-06-12 | Michael Black | Multiple laser treatment |
US20030109787A1 (en) * | 2001-12-12 | 2003-06-12 | Michael Black | Multiple laser diagnostics |
US7056318B2 (en) * | 2002-04-12 | 2006-06-06 | Reliant Technologies, Inc. | Temperature controlled heating device and method to heat a selected area of a biological body |
JP2005535370A (en) | 2002-06-19 | 2005-11-24 | パロマー・メディカル・テクノロジーズ・インコーポレイテッド | Method and apparatus for treating skin and subcutaneous conditions |
US20050055070A1 (en) * | 2003-03-07 | 2005-03-10 | Gareth Jones | Method and device for treatment of skin conditions |
AU2004226378A1 (en) | 2003-03-27 | 2004-10-14 | The General Hospital Corporation | Method and apparatus for dermatological treatment and fractional skin resurfacing |
US7282060B2 (en) | 2003-12-23 | 2007-10-16 | Reliant Technologies, Inc. | Method and apparatus for monitoring and controlling laser-induced tissue treatment |
US7184184B2 (en) * | 2003-12-31 | 2007-02-27 | Reliant Technologies, Inc. | High speed, high efficiency optical pattern generator using rotating optical elements |
US7196831B2 (en) * | 2003-12-31 | 2007-03-27 | Reliant Technologies, Inc. | Two-dimensional optical scan system using a counter-rotating disk scanner |
US7090670B2 (en) | 2003-12-31 | 2006-08-15 | Reliant Technologies, Inc. | Multi-spot laser surgical apparatus and method |
US7372606B2 (en) | 2003-12-31 | 2008-05-13 | Reliant Technologies, Inc. | Optical pattern generator using a single rotating component |
US7413572B2 (en) | 2004-06-14 | 2008-08-19 | Reliant Technologies, Inc. | Adaptive control of optical pulses for laser medicine |
GB0414113D0 (en) | 2004-06-24 | 2004-07-28 | Virulite Distrib Ltd | Cosmetic uses of electromagnetic radiation |
CN1984696A (en) * | 2004-07-16 | 2007-06-20 | 强生消费者公司 | Treatment of skin with light and a benefit agent |
GB2416699B (en) * | 2004-08-05 | 2010-04-14 | Photo Therapeutics Ltd | Skin rejuvenation |
US20070231255A1 (en) * | 2004-08-13 | 2007-10-04 | Derma Laser Inc | Method for the Treatment of Mammalian Skin Tissues Via Pulse Irradiation in the Presence of a Photoactive Compound |
EP1776158A1 (en) * | 2005-04-14 | 2007-04-25 | Francesco Peluso | Portable electric stimulator for wrinkles with interchangeable microelectrodes applicator |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
US20060293728A1 (en) * | 2005-06-24 | 2006-12-28 | Roersma Michiel E | Device and method for low intensity optical hair growth control |
US20080146970A1 (en) * | 2005-12-06 | 2008-06-19 | Julia Therapeutics, Llc | Gel dispensers for treatment of skin with acoustic energy |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
US20100211059A1 (en) | 2007-04-19 | 2010-08-19 | Deem Mark E | Systems and methods for creating an effect using microwave energy to specified tissue |
EP2532320A3 (en) | 2007-04-19 | 2013-04-03 | Miramar Labs, Inc. | Apparatus for reducing sweat production |
EP2837351B1 (en) | 2007-04-19 | 2018-05-30 | Miramar Labs, Inc. | Systems for creating an effect using microwave energy to specified tissue |
JP2010524589A (en) | 2007-04-19 | 2010-07-22 | ザ ファウンドリー, インコーポレイテッド | Method, apparatus and system for non-invasive delivery of microwave therapy |
US9849304B2 (en) * | 2007-08-02 | 2017-12-26 | Gustavsson Nevada Holding Llc | Device and method for treatment of organic tissue |
US8200932B2 (en) * | 2007-10-19 | 2012-06-12 | Virident Systems Inc. | Managing memory systems containing components with asymmetric characteristics |
EP2231274B1 (en) | 2007-12-12 | 2014-03-12 | Miramar Labs, Inc. | System and apparatus for the noninvasive treatment of tissue using microwave energy |
KR102052152B1 (en) | 2007-12-12 | 2020-01-08 | 미라마 랩스 인코포레이티드 | A disposable medical apparatus for use with an applicator which radiates microwave energy |
US9155905B2 (en) | 2008-01-16 | 2015-10-13 | Morgan Lars Ake Gustavsson | Fluorescent handpiece |
US7955367B2 (en) | 2008-01-16 | 2011-06-07 | Morgan Gustavsson | Fluorescent handpiece |
US8465532B2 (en) | 2008-01-16 | 2013-06-18 | Morgan Lars Ake Gustavsson | Fluorescent handpiece |
EP2907465A1 (en) | 2008-04-17 | 2015-08-19 | Miramar Labs, Inc. | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy |
US9314301B2 (en) | 2011-08-01 | 2016-04-19 | Miramar Labs, Inc. | Applicator and tissue interface module for dermatological device |
KR102183581B1 (en) | 2012-04-18 | 2020-11-27 | 싸이노슈어, 엘엘씨 | Picosecond laser apparatus and methods for treating target tissues with same |
WO2014145707A2 (en) | 2013-03-15 | 2014-09-18 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
WO2015013502A2 (en) | 2013-07-24 | 2015-01-29 | Miramar Labs, Inc. | Apparatus and methods for the treatment of tissue using microwave energy |
AU2018297103A1 (en) * | 2017-07-06 | 2020-01-30 | Boston Scientific Scimed, Inc. | Optical fibers and associated systems |
CN112042066A (en) | 2018-02-26 | 2020-12-04 | 赛诺秀股份有限公司 | Q-switched cavity-tilting subnanosecond laser |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3329257A1 (en) * | 1983-08-12 | 1985-02-28 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | FLUOROMETER |
WO1986002783A1 (en) * | 1984-10-25 | 1986-05-09 | Candela Corporation | Long pulse tunable dye laser |
WO1991013653A1 (en) | 1990-03-14 | 1991-09-19 | Candela Laser Corporation | Apparatus and method of treating pigmented lesions using pulsed irradiation |
SE465953B (en) * | 1990-04-09 | 1991-11-25 | Morgan Gustafsson | DEVICE FOR TREATMENT OF UNDESECTED EXTERNAL ACCOMMODATIONS |
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
US5439954A (en) * | 1991-10-11 | 1995-08-08 | The Procter & Gamble Company | Substituted phenyl-1,3-diketones as protectants against skin damage |
US5272716A (en) * | 1991-10-15 | 1993-12-21 | Mcdonnell Douglas Corporation | Hand held laser apparatus |
US5626631A (en) * | 1992-10-20 | 1997-05-06 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5720772A (en) * | 1992-10-20 | 1998-02-24 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5620478A (en) * | 1992-10-20 | 1997-04-15 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5707403A (en) * | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
US5616140A (en) * | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
JP3263275B2 (en) * | 1994-04-05 | 2002-03-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus |
EP0843577A1 (en) * | 1994-12-09 | 1998-05-27 | Cynosure, Inc. | Near-infrared selective photothermolysis for vascular targets |
GB9508499D0 (en) * | 1995-04-26 | 1995-06-14 | Olavesen Limited | Improvements in or relating to cosmetic treatment of skin lines |
US5660836A (en) * | 1995-05-05 | 1997-08-26 | Knowlton; Edward W. | Method and apparatus for controlled contraction of collagen tissue |
US5624435A (en) * | 1995-06-05 | 1997-04-29 | Cynosure, Inc. | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor |
US5658323A (en) * | 1995-07-12 | 1997-08-19 | Miller; Iain D. | Method and apparatus for dermatology treatment |
US5964749A (en) * | 1995-09-15 | 1999-10-12 | Esc Medical Systems Ltd. | Method and apparatus for skin rejuvenation and wrinkle smoothing |
US5776175A (en) * | 1995-09-29 | 1998-07-07 | Esc Medical Systems Ltd. | Method and apparatus for treatment of cancer using pulsed electromagnetic radiation |
GB9602375D0 (en) | 1996-02-06 | 1996-04-03 | Jones Gary L | Laser depilation apparatus and method |
US5602948A (en) * | 1996-04-09 | 1997-02-11 | Currie; Joseph E. | Fiber optic illumination device |
US5759200A (en) * | 1996-09-04 | 1998-06-02 | Azar; Zion | Method of selective photothermolysis |
CA2198826A1 (en) | 1997-02-28 | 1998-08-28 | Denis K. Dudley | Laser treatment of telangiectasia |
-
1996
- 1996-08-29 GB GBGB9618051.8A patent/GB9618051D0/en active Pending
-
1997
- 1997-08-28 US US08/919,472 patent/US5983900A/en not_active Expired - Lifetime
- 1997-08-28 ZA ZA9707751A patent/ZA977751B/en unknown
- 1997-08-29 NZ NZ334910A patent/NZ334910A/en unknown
- 1997-08-29 CA CA002265041A patent/CA2265041C/en not_active Expired - Fee Related
- 1997-08-29 AU AU39511/97A patent/AU3951197A/en not_active Abandoned
- 1997-08-29 DE DE69728779T patent/DE69728779T2/en not_active Expired - Lifetime
- 1997-08-29 WO PCT/GB1997/002322 patent/WO1998008568A1/en active IP Right Grant
- 1997-08-29 EP EP97936817A patent/EP0932431B1/en not_active Expired - Lifetime
- 1997-08-29 ES ES97936817T patent/ES2218695T3/en not_active Expired - Lifetime
- 1997-08-29 JP JP10511395A patent/JP2000517211A/en active Pending
-
1999
- 1999-03-05 US US09/263,422 patent/US6443946B2/en not_active Expired - Fee Related
-
2001
- 2001-12-27 US US09/981,077 patent/US20020045891A1/en not_active Abandoned
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100055789A1 (en) * | 1998-11-30 | 2010-03-04 | Mcdaniel David H | Method and apparatus for the stimulation of hair growth |
US8651112B2 (en) | 1998-11-30 | 2014-02-18 | David McDaniel | Process for treatment of psoriasis |
US9017391B2 (en) | 1998-11-30 | 2015-04-28 | L'oreal | Method and apparatus for skin treatment |
US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US9227082B2 (en) | 1998-11-30 | 2016-01-05 | L'oreal | Method and apparatus for acne treatment using low intensity light therapy |
US9814906B2 (en) | 1998-11-30 | 2017-11-14 | L'oreal | Method and apparatus for skin treatment |
US8651111B2 (en) * | 2003-04-10 | 2014-02-18 | David H. McDaniel | Photomodulation methods and devices for regulating cell proliferation and gene expression |
US9144690B2 (en) | 2003-07-31 | 2015-09-29 | L'oreal | System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
CN108187240A (en) * | 2017-12-15 | 2018-06-22 | 重庆云帆医疗设备有限公司 | A kind of anti-wrinkle therapeutic equipment |
Also Published As
Publication number | Publication date |
---|---|
NZ334910A (en) | 2000-01-28 |
WO1998008568A1 (en) | 1998-03-05 |
DE69728779D1 (en) | 2004-05-27 |
DE69728779T2 (en) | 2005-04-28 |
US20020045891A1 (en) | 2002-04-18 |
ES2218695T3 (en) | 2004-11-16 |
US5983900A (en) | 1999-11-16 |
CA2265041A1 (en) | 1998-03-05 |
US6443946B2 (en) | 2002-09-03 |
ZA977751B (en) | 1998-03-20 |
GB9618051D0 (en) | 1996-10-09 |
CA2265041C (en) | 2002-07-02 |
EP0932431A1 (en) | 1999-08-04 |
AU3951197A (en) | 1998-03-19 |
JP2000517211A (en) | 2000-12-26 |
EP0932431B1 (en) | 2004-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6443946B2 (en) | Apparatus for wrinkle removal | |
US6881212B1 (en) | Skin wrinkle reduction using pulsed light | |
US6106514A (en) | Laser method for subsurface cutaneous treatment | |
US6808532B2 (en) | Laser treatment for reducing wrinkles | |
US5683380A (en) | Method and apparatus for depilation using pulsed electromagnetic radiation | |
US6197020B1 (en) | Laser apparatus for subsurface cutaneous treatment | |
US6077294A (en) | Method for non-invasive wrinkle removal and skin treatment | |
US5885273A (en) | Method for depilation using pulsed electromagnetic radiation | |
US20050215988A1 (en) | Method and apparatus for medical treatment utilizing long duration electromagnetic radiation | |
CA2251555A1 (en) | Alexandrite laser system for treatment of dermatological specimens | |
EP0601130A1 (en) | Hair removal device and method | |
US20070239147A1 (en) | Method, system and apparatus for dermatological treatment and fractional skin resurfacing | |
US6702838B1 (en) | Method of treating hypotrophic scars enlarged pores | |
US20140330258A1 (en) | Medical laser apparatus | |
US20050065503A1 (en) | Method and apparatus for reducing the appearance of skin markings | |
WO2001074265A1 (en) | Dual-wavelength laser-treatment of vascular disorders | |
JPH11113923A (en) | Pulse-shaped light source | |
RU2234960C1 (en) | Method for removing wrinkles and juvenalizing skin in non-invasive way | |
Renton | Metal vapor lasers for medical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ICN PHOTONICS LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CLEMENT, ROBERT MARC;KIERAN, MICHAEL N.;REEL/FRAME:011211/0402 Effective date: 20001026 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20060903 |